Authors:
VANBESIEN K
HA CS
MURPHY S
MCLAUGHLIN P
RODRIGUEZ A
AMIN K
FORMAN A
ROMAGUERA J
HAGEMEISTER F
YOUNES A
BACHIER C
SARRIS A
SOBOCINSKI KS
COX JD
CABANILLAS F
Citation: K. Vanbesien et al., RISK-FACTORS, TREATMENT, AND OUTCOME OF CENTRAL-NERVOUS-SYSTEM RECURRENCE IN ADULTS WITH INTERMEDIATE-GRADE AND IMMUNOBLASTIC LYMPHOMA, Blood, 91(4), 1998, pp. 1178-1184
Authors:
LUTHRA R
MCBRIDE JA
CABANILLAS F
SARRIS A
Citation: R. Luthra et al., NOVEL 5'-EXONUCLEASE-BASED REAL-TIME PCR ASSAY FOR THE DETECTION OF T(14-18)(Q32-Q21) IN PATIENTS WITH FOLLICULAR LYMPHOMA, The American journal of pathology, 153(1), 1998, pp. 63-68
Citation: A. Sarris, A NEW HUMAN HERPESVIRUS AS A FACTOR IN THE PATHOGENESIS OF KAPOSIS-SARCOMA AND BODY-CAVITY LYMPHOMA, The cancer journal from Scientific American, 3(3), 1997, pp. 140-141
Authors:
HAZARIKA P
DUONG DMT
HAGER C
HAKINZADEH M
SARRIS A
NAGPAL S
THACHER S
CHANDRARATNA RAS
DUVIC M
Citation: P. Hazarika et al., INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES, Journal of investigative dermatology, 108(4), 1997, pp. 204-204
Authors:
BREUERMCHAM J
LEDBETTER L
MARSHALL G
SARRIS A
DUVIC M
Citation: J. Breuermcham et al., CYTOKINE PROFILES DISTINGUISH AIDS-RELATED SKIN DISEASES, Journal of investigative dermatology, 108(4), 1997, pp. 286-286
Authors:
YOUNES A
AYOUB JP
SARRIS A
HAGEMEISTER F
NORTH L
PATE O
MCLAUGHLIN P
RODRIGUEZ MA
ROMAGUERA J
KURZROCK R
PRETI A
BACHIER C
SMITH T
CABANILLAS F
Citation: A. Younes et al., PACLITAXEL ACTIVITY FOR THE TREATMENT OF NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A PHASE-II TRIAL, British Journal of Haematology, 96(2), 1997, pp. 328-332
Authors:
HAGEMEISTER FB
HA C
ROMAGUERA J
MCLAUGHLIN P
RODRIGUEZ A
YOUNES A
SARRIS A
CABANILLAS F
TUCKER S
HESS M
COX J
Citation: Fb. Hagemeister et al., THE POST-THERAPY GALLIUM SCAN (GS) IN CLINICALLY STAGED SUPRADIAPHRAGMATIC I-II HODGKINS-DISEASE (HD) IS THE MOST IMPORTANT PREDICTOR OF FREEDOM FROM PROGRESSION (FFP), Blood, 90(10), 1997, pp. 3898-3898
Authors:
ROMAGUERA J
KHOURI I
HAGEMEISTER FB
RODRIGUEZ MA
MCLAUGHLIN P
SARRIS A
YOUNES A
KEATING MJ
KOLLER C
OBRIEN S
RIGGS S
KANTARJIAN H
CHAMPLIN R
CABANILLAS F
Citation: J. Romaguera et al., HCVAD ARA-C-MTX (HCVAD/A-M) WITH OR WITHOUT HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSFUSION (SCT) AS SALVAGE FOR RELAPSED OR REFRACTORY DIFFUSE/MODULAR MANTLE CELL LYMPHOMA (MCL)/, Blood, 90(10), 1997, pp. 834-834
Authors:
FAYAD L
PODOLOFF D
RODRIGUEZ J
HAGEMEISTER F
YOUNES A
SARRIS A
RODRIGUEZ MA
ROMAGUERA J
MCLAUGHLIN P
CABANILLAS F
Citation: L. Fayad et al., GALLIUM (GA-67) SCAN RESULT AFTER 2ND-COURSE OF CHEMOTHERAPY CORRELATES WITH CLINICAL OUTCOME IN AGGRESSIVE POOR-PROGNOSIS NON-HODGKINS-LYMPHOMAS (APPNHL) TREATED WITH ALTERNATING TRIPLE THERAPY REGIMEN (ATT), Blood, 90(10), 1997, pp. 836-836
Authors:
CABANILLAS F
ROMAGUERA J
HAGEMEISTER FB
YOUNES A
MCLAUGHLIN P
SARRIS A
RODRIGUEZ MA
Citation: F. Cabanillas et al., RANDOMIZED STUDY OF IDARBUBICIN (IDA) VS ADRIAMYCIN (ADRIA)-BASED COMBINATION CHEMOTHERAPY FOR AGGRESSIVE POOR-PROGNOSIS (TUMOR SCORE GREATER-THAN-OR-EQUAL-TO-3) NON-HODGKINS-LYMPHOMAS (APPNHL), Blood, 90(10), 1997, pp. 1093-1093
Authors:
RODRIGUEZ J
RODRIGUEZ MA
FAYAD L
HAGEMEISTER B
MCLAUGHLIN P
SWAN F
SARRIS A
ROMAGUERA J
ANDERSSON B
CABANILLAS F
Citation: J. Rodriguez et al., ASAP IS AN EFFECTIVE SALVAGE REGIMEN IN PATIENTS WITH REFRACTORY OR RECURRENT HODGKINS-DISEASE, Blood, 90(10), 1997, pp. 1518-1518
Citation: Hj. Cristau et al., A NEW WAY FOR POTENTIAL AMINOPHOSPHONIC ACIDS PRECURSORS, Phosphorus, sulfur and silicon and the related elements, 111(1-4), 1996, pp. 757-757
Authors:
BROXMEYER HE
COOPER S
LI ZH
LU L
SARRIS A
WANG MH
CHANG MS
DONNER DB
LEONARD EJ
Citation: He. Broxmeyer et al., MACROPHAGE-STIMULATING PROTEIN, A LIGAND FOR THE RON RECEPTOR PROTEIN-TYROSINE KINASE, SUPPRESSES MYELOID PROGENITOR-CELL PROLIFERATION ANDSYNERGIZES WITH VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR AND MEMBERS OF THE CHEMOKINE FAMILY, Annals of hematology, 73(1), 1996, pp. 1-9
Authors:
YOUNES A
CABANILLAS F
MCLAUGHLIN PW
HAGEMEISTER FB
FARBER C
SARRIS A
PATE O
MYERS J
PORTLOCK C
Citation: A. Younes et al., PRELIMINARY EXPERIENCE WITH PACLITAXEL FOR THE TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 7(10), 1996, pp. 1083-1085
Authors:
YOUNES A
AYOUB JP
HAGEMEISTER FB
MCLAUGHLIN P
SARRIS A
RODRIGUEZ MA
SWAN F
ROMAGUERA JE
MARTIN J
CABANILLAS F
Citation: A. Younes et al., NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE, Journal of clinical oncology, 14(2), 1996, pp. 543-548
Authors:
SARRIS A
ULMER R
DALIANI D
JACKOW C
DUVIC M
Citation: A. Sarris et al., INTERFERON-INDUCIBLE PROTEIN-10, TNF-ALPHA AND IFN-GAMMA ARE COEXPRESSED IN CUTANEOUS T-CELL LYMPHOMA LESIONS, Journal of investigative dermatology, 106(4), 1996, pp. 192-192
Authors:
GRECO E
KALPAXIS T
SCHNAPP A
VIVIERS D
DAMBROSIO I
GUY M
LICOPPE C
OSANNA M
SARRIS A
SCHNAPPGOURBEILLON A
SIARD H
THEODORESCU D
TSIGONAKI C
TSINGARIDA A
VAFIDIS A
XANTHOPOULOU M
Citation: A. Sarris et al., INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA EXPRESSION IN MYCOSIS-FUNGOIDES PROGRESSION - RESPONSE, Blood, 88(2), 1996, pp. 758-758
Authors:
VANBESIAN K
HA CS
FORMAN A
MCLAUGHLIN P
RODRIGUEZ A
ROMAGUERA J
HAGEMEISTER F
YOUNES A
BACHLER C
SARRIS A
COX J
CABANILLAS F
Citation: K. Vanbesian et al., CENTRAL-NERVOUS-SYSTEM (CNS) RECURRENCE OF LYMPHOMA (NHL) IN THE ADULT - INCIDENCE, PROGNOSIS, AND IMPACT OF TREATMENT, Blood, 88(10), 1996, pp. 356-356